Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer

Ann Surg Oncol. 2018 Sep;25(9):2498-2499. doi: 10.1245/s10434-018-6610-7. Epub 2018 Jul 3.
No abstract available

Publication types

  • Editorial

MeSH terms

  • BCG Vaccine / therapeutic use*
  • Humans
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / metabolism*
  • Programmed Cell Death 1 Receptor / metabolism*
  • Treatment Failure
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / metabolism*

Substances

  • BCG Vaccine
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor